FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137809739> ?p ?o ?g. }

• W2137809739 endingPage "2832" @default.
• W2137809739 startingPage "2825" @default.
• W2137809739 abstract "To analyze fertility in male patients treated with various combinations of radiotherapy and chemotherapy, with or without alkylating agents, or with radiotherapy alone for Hodgkin's lymphoma.Follicle-stimulating hormone (FSH) levels were measured in patients with early-stage upper-diaphragmatic disease enrolled in four European Organisation for Research and Treatment of Cancer (EORTC) trials (H6-H9). Median follow-up after therapy was 32 months. Patients with FSH measurement at least 12 months after end of treatment (n = 355) were selected to assess post-treatment fertility. Patients with FSH measurement 0 to 9 months after therapy (n = 349) were selected to analyze fertility recovery; of these, patients with elevated FSH (> 10 U/L; n = 101) were followed until recovery. Factors predictive for therapy-related infertility were assessed by logistic regression.The proportion of elevated FSH was 3% and 8% in patients treated with radiotherapy only or with nonalkylating chemotherapy (doxorubicin, bleomycin, vinblastine, dacarbazine [ABVD], epirubicin, bleomycin, vinblastine, prednisone [EBVP]); it was 60% (P < .001) after chemotherapy containing alkylating agents (mechlorethamine, vincristine, procarbazine, prednisone [MOPP], MOPP/doxorubicin, bleomycin, vinblastine [ABV], bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone [BEACOPP]). After a median time of 19 months, recovery of fertility occurred in 82% of patients treated without alkylating chemotherapy. This proportion was 30%, statistically (P < .001) lower in those treated with alkylating chemotherapy, and median time to recovery was 27 months. The post-treatment proportion of elevated FSH increased significantly (P < .001) with the dose of alkylating chemotherapy administered, and recovery was less frequent and slower after higher doses. Age more than 50 years and stage II disease also contributed to poor outcome.Fertility can be secured after nonalkylating chemotherapy for Hodgkin's lymphoma. In contrast, alkylating chemotherapy has a dismal effect, even after a limited number of cycles." @default.
• W2137809739 created "2016-06-24" @default.
• W2137809739 creator A5000349515 @default.
• W2137809739 creator A5011615789 @default.
• W2137809739 creator A5023992858 @default.
• W2137809739 creator A5026185552 @default.
• W2137809739 creator A5033149886 @default.
• W2137809739 creator A5042799541 @default.
• W2137809739 creator A5046699735 @default.
• W2137809739 creator A5064102980 @default.
• W2137809739 creator A5065824311 @default.
• W2137809739 creator A5070508738 @default.
• W2137809739 creator A5081216142 @default.
• W2137809739 creator A5084274613 @default.
• W2137809739 date "2007-07-01" @default.
• W2137809739 modified "2023-10-16" @default.
• W2137809739 title "Gonadal Function in Males After Chemotherapy for Early-Stage Hodgkin's Lymphoma Treated in Four Subsequent Trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Étude des Lymphomes de l'Adulte" @default.
• W2137809739 cites W1806394164 @default.
• W2137809739 cites W1883598689 @default.
• W2137809739 cites W1965603638 @default.
• W2137809739 cites W1992270775 @default.
• W2137809739 cites W2014698797 @default.
• W2137809739 cites W2027853545 @default.
• W2137809739 cites W2075898541 @default.
• W2137809739 cites W2089765255 @default.
• W2137809739 cites W2092015388 @default.
• W2137809739 cites W2114191964 @default.
• W2137809739 cites W2114574605 @default.
• W2137809739 cites W2122491991 @default.
• W2137809739 cites W2124312531 @default.
• W2137809739 cites W2126942292 @default.
• W2137809739 cites W2127683216 @default.
• W2137809739 cites W2134796102 @default.
• W2137809739 cites W2134931633 @default.
• W2137809739 cites W2156906636 @default.
• W2137809739 cites W2157764660 @default.
• W2137809739 cites W2165308914 @default.
• W2137809739 cites W2185580724 @default.
• W2137809739 cites W2240337495 @default.
• W2137809739 cites W2246556650 @default.
• W2137809739 cites W2291147076 @default.
• W2137809739 cites W2328676772 @default.
• W2137809739 cites W2555831663 @default.
• W2137809739 cites W2558967114 @default.
• W2137809739 doi "https://doi.org/10.1200/jco.2006.10.2020" @default.
• W2137809739 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17515571" @default.
• W2137809739 hasPublicationYear "2007" @default.
• W2137809739 type Work @default.
• W2137809739 sameAs 2137809739 @default.
• W2137809739 citedByCount "88" @default.
• W2137809739 countsByYear W21378097392012 @default.
• W2137809739 countsByYear W21378097392013 @default.
• W2137809739 countsByYear W21378097392014 @default.
• W2137809739 countsByYear W21378097392015 @default.
• W2137809739 countsByYear W21378097392016 @default.
• W2137809739 countsByYear W21378097392017 @default.
• W2137809739 countsByYear W21378097392018 @default.
• W2137809739 countsByYear W21378097392019 @default.
• W2137809739 countsByYear W21378097392020 @default.
• W2137809739 countsByYear W21378097392022 @default.
• W2137809739 countsByYear W21378097392023 @default.
• W2137809739 crossrefType "journal-article" @default.
• W2137809739 hasAuthorship W2137809739A5000349515 @default.
• W2137809739 hasAuthorship W2137809739A5011615789 @default.
• W2137809739 hasAuthorship W2137809739A5023992858 @default.
• W2137809739 hasAuthorship W2137809739A5026185552 @default.
• W2137809739 hasAuthorship W2137809739A5033149886 @default.
• W2137809739 hasAuthorship W2137809739A5042799541 @default.
• W2137809739 hasAuthorship W2137809739A5046699735 @default.
• W2137809739 hasAuthorship W2137809739A5064102980 @default.
• W2137809739 hasAuthorship W2137809739A5065824311 @default.
• W2137809739 hasAuthorship W2137809739A5070508738 @default.
• W2137809739 hasAuthorship W2137809739A5081216142 @default.
• W2137809739 hasAuthorship W2137809739A5084274613 @default.
• W2137809739 hasBestOaLocation W21378097394 @default.
• W2137809739 hasConcept C126322002 @default.
• W2137809739 hasConcept C141071460 @default.
• W2137809739 hasConcept C143998085 @default.
• W2137809739 hasConcept C2776232574 @default.
• W2137809739 hasConcept C2776305933 @default.
• W2137809739 hasConcept C2776694085 @default.
• W2137809739 hasConcept C2776755627 @default.
• W2137809739 hasConcept C2777132456 @default.
• W2137809739 hasConcept C2778720950 @default.
• W2137809739 hasConcept C2779112685 @default.
• W2137809739 hasConcept C2779429289 @default.
• W2137809739 hasConcept C2780964509 @default.
• W2137809739 hasConcept C509974204 @default.
• W2137809739 hasConcept C71924100 @default.
• W2137809739 hasConcept C90924648 @default.
• W2137809739 hasConceptScore W2137809739C126322002 @default.
• W2137809739 hasConceptScore W2137809739C141071460 @default.
• W2137809739 hasConceptScore W2137809739C143998085 @default.
• W2137809739 hasConceptScore W2137809739C2776232574 @default.
• W2137809739 hasConceptScore W2137809739C2776305933 @default.
• W2137809739 hasConceptScore W2137809739C2776694085 @default.
• W2137809739 hasConceptScore W2137809739C2776755627 @default.
• W2137809739 hasConceptScore W2137809739C2777132456 @default.

• next